Riggs B Lawrence, Melton L Joseph, Robb Richard A, Camp Jon J, Atkinson Elizabeth J, McDaniel Lisa, Amin Shreyasee, Rouleau Peggy A, Khosla Sundeep
Endocrine Research Unit, Division of Endocrinology and Metabolism, Mayo Clinic College of Medicine, Rochester, Minnesota, USA.
J Bone Miner Res. 2008 Feb;23(2):205-14. doi: 10.1359/jbmr.071020.
Using QCT, we made a longitudinal, population-based assessment of rates of bone loss over life at the distal radius, distal tibia, and lumbar spine. Cortical bone loss began in perimenopause in women and later in life in men. In contrast, trabecular bone loss began in young adulthood in both sexes.
Although conventional wisdom holds that bone loss begins at menopause in women and later in life in men, this has not been examined longitudinally in population-based studies using precise technology capable of distinguishing cortical and trabecular bone.
In an age- and sex-stratified population sample (n = 553), we measured volumetric BMD (vBMD) of trabecular and cortical bone by QCT annually for up to 3 yr at the distal radius (DR) and distal tibia (DT) (n = 552) and trabecular vBMD at baseline and 3 yr at the lumbar spine (LS) (n = 474).
Substantial cortical bone loss began in middle life in women but began mainly after age 75 in men. In contrast, substantial trabecular bone loss began in young adult women and men at all three skeletal sites and continued throughout life with acceleration during perimenopause in women. Women experienced 37% and men experienced 42% of their total lifetime trabecular bone loss before age 50 compared with 6% and 15%, respectively, for cortical bone. Median rates of change in trabecular bone (%/yr) were -0.40, -0.24, and -1.61 in young adult women and -0.38, -0.40, and -0.84 in young adult men at the DR, DT, and LS, respectively (all p < 0.001). The early trabecular bone loss did not consistently correlate with putative causal factors, except for a trend with IGF-related variables at DT in women. However, in postmenopausal women and, to a lesser extent, in older men, higher rates of cortical and trabecular bone loss were associated with lower levels of biologically-active sex steroids and with higher levels of follicle-stimulating hormone and bone turnover markers.
The late onset of cortical bone loss is temporally associated with sex steroid deficiency. However, the early-onset, substantial trabecular bone loss in both sexes during sex steroid sufficiency is unexplained and indicates that current paradigms on the pathogenesis of osteoporosis are incomplete.
我们使用定量计算机断层扫描(QCT)对桡骨远端、胫骨远端和腰椎的一生中骨质流失率进行了基于人群的纵向评估。女性皮质骨流失始于围绝经期,男性则始于生命后期。相比之下,小梁骨流失在男女两性的青年期就已开始。
尽管传统观点认为女性骨质流失始于绝经,男性则始于生命后期,但尚未在基于人群的研究中使用能够区分皮质骨和小梁骨的精确技术进行纵向研究。
在一个按年龄和性别分层的人群样本(n = 553)中,我们通过QCT每年测量桡骨远端(DR)和胫骨远端(DT)(n = 552)的小梁骨和皮质骨的体积骨密度(vBMD),为期3年,并在基线和3年时测量腰椎(LS)的小梁vBMD(n = 474)。
女性的大量皮质骨流失始于中年,而男性主要始于75岁以后。相比之下,大量小梁骨流失在青年期的男女两性的所有三个骨骼部位就已开始,并在女性围绝经期加速,持续终生。与皮质骨分别为6%和15%相比,女性在50岁之前经历了其一生中小梁骨总流失的37%,男性为42%。青年期女性在DR、DT和LS处小梁骨变化的中位数速率(%/年)分别为 -0.40、-0.24和 -1.61,青年期男性分别为 -0.38、-0.40和 -0.84(所有p < 0.001)。除了女性在DT处与胰岛素样生长因子相关变量有一定趋势外,早期小梁骨流失与假定的因果因素没有一致的相关性。然而,在绝经后女性以及在较小程度上在老年男性中,较高的皮质骨和小梁骨流失率与生物活性性激素水平较低以及促卵泡激素和骨转换标志物水平较高有关。
皮质骨流失的延迟发生在时间上与性激素缺乏有关。然而,在性激素充足的情况下,男女两性早期出现的大量小梁骨流失无法解释,这表明目前关于骨质疏松症发病机制的范式是不完整的。